Status:
WITHDRAWN
Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery
Lead Sponsor:
Henry Ford Health System
Conditions:
Post Operative Pain
Eligibility:
FEMALE
18-55 years
Phase:
PHASE4
Brief Summary
This study will evaluate the ability of dexamethasone to enhance labor epidurals when administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing elective cesarean se...
Detailed Description
This study will evaluate the ability of dexamethasone to enhance labor epidurals when administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing elective cesarean se...
Eligibility Criteria
Inclusion
- Parturients in their 3rd trimester who are receiving a planned cesarean delivery
- Primiparous and multiparous pregnancies
- American Society of Anesthesia (ASA) classes 1, 2 , and 3
Exclusion
- Patients for whom neuraxial anesthesia was either declined, unsuccessful, or contraindicated
- Gestational Diabetics
- Diabetics
- Patients allergic to dexamethasone, local anesthetics, or opioids
- Patients that are immunosuppressed
- Patient who received systemic steroids within the preceding 48 hours
Key Trial Info
Start Date :
May 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03877549
Start Date
May 24 2019
End Date
June 15 2022
Last Update
September 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202